Special issue: Extracellular matrix: Therapeutic tools and targets in cancer treatment.

作者: Liliana Schaefer , Dieter P. Reinhardt

DOI: 10.1016/J.ADDR.2016.01.001

关键词: Drug deliveryCell biologyInteractomeBiologyExtracellular matrixTumor microenvironmentTissue homeostasisSignal transductionIntegrinFibronectin

摘要: Extracellular matrix (ECM) constituents play not only structural roles during development and tissue homeostasis, but also many biological functions throughout life. Molecular diversity a vast interactome provide the basis for this multi-functionality. Moreover, native or processed ECM molecules interact with various receptors, thereby activating signaling pathways that control cell differentiation, proliferation, adhesion migration, all relevant to tumor biology. Thus, there is an emerging field focused on exploiting components as novel therapeutic targets in treatment of cancer other diseases, providing potent tools advance drug delivery penetration. In special issue we critical appraisal focusing on: 1) proteins (matricellular proteins, collagen, elastin, fibronectin, proteoglycans), integrins, protease-facilitated delivery; 2) ECM-derived therapeutics (hyaluronan, heparin, heparan sulfate), 3) ECM-like biomaterials, 4) determinant efficacy, emphasis applications treatment.

参考文章(46)
José Carlos Rodríguez-Cabello, Alessandra Girotti, Artur Ribeiro, Francisco Javier Arias, Synthesis of genetically engineered protein polymers (recombinamers) as an example of advanced self-assembled smart materials. Methods of Molecular Biology. ,vol. 811, pp. 17- 38 ,(2012) , 10.1007/978-1-61779-388-2_2
Laura M Drogowski, Stergios J Moschos, John M Kirkwood, Shelley L Reppert, Integrins and cancer. Oncology. ,vol. 21, pp. 13- 20 ,(2007)
Hinke A.B. Multhaupt, Birgit Leitinger, Donald Gullberg, John R. Couchman, Extracellular matrix component signaling in cancer. Advanced Drug Delivery Reviews. ,vol. 97, pp. 28- 40 ,(2016) , 10.1016/J.ADDR.2015.10.013
Thomas Neill, Liliana Schaefer, Renato V. Iozzo, Decorin as a multivalent therapeutic agent against cancer Advanced Drug Delivery Reviews. ,vol. 97, pp. 174- 185 ,(2016) , 10.1016/J.ADDR.2015.10.016
Kai Kessenbrock, Chih-Yang Wang, Zena Werb, Matrix metalloproteinases in stem cell regulation and cancer Matrix Biology. ,vol. 44, pp. 184- 190 ,(2015) , 10.1016/J.MATBIO.2015.01.022
G S Wong, A K Rustgi, Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. British Journal of Cancer. ,vol. 108, pp. 755- 761 ,(2013) , 10.1038/BJC.2012.592
Amanda Weyers, Bo Yang, Dae Sung Yoon, Jong-Hwan Park, Fuming Zhang, Kyung Bok Lee, Robert J. Linhardt, A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology? Omics A Journal of Integrative Biology. ,vol. 16, pp. 79- 89 ,(2012) , 10.1089/OMI.2011.0102
Joanne E. Murphy-Ullrich, E. Helene Sage, Revisiting the matricellular concept. Matrix Biology. ,vol. 37, pp. 1- 14 ,(2014) , 10.1016/J.MATBIO.2014.07.005
Mauro Ferrari, Cancer nanotechnology: opportunities and challenges Nature Reviews Cancer. ,vol. 5, pp. 161- 171 ,(2005) , 10.1038/NRC1566
Mina J Bissell, William C Hines, None, Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nature Medicine. ,vol. 17, pp. 320- 329 ,(2011) , 10.1038/NM.2328